BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 9302382)

  • 1. Ocular naevus and melanoma in acromegaly.
    Corcuff JB; Ogor C; Kerlan V; Rougier MB; Bercovichi M; Roger P
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):119-21. PubMed ID: 9302382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric primary malignant melanomas of the choroid: two separate malignant melanomas of the choroid and two uveal naevi in one eye.
    Völcker HE; Naumann GO
    Br J Ophthalmol; 1978 Jun; 62(6):408-13. PubMed ID: 666990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma knife radiosurgery for acromegaly--long-term experience.
    Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
    Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
    Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly.
    Abe T; Lüdecke DK
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):27-35. PubMed ID: 10341853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.
    Popovic V; Damjanovic S; Micic D; Nesovic M; Djurovic M; Petakov M; Obradovic S; Zoric S; Simic M; Penezic Z; Marinkovic J
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):441-5. PubMed ID: 9876340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the outcome of surgical treatment of acromegaly.
    Er LK; Chang TC; Lin SM; Huang KM; Chang CC
    J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J; Vance ML; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carpal tunnel syndrome in acromegaly--4-case report and review of literature].
    Imamura H; Isu T; Iwasaki Y; Sugimoto S; Abe H; Tashiro K
    Hokkaido Igaku Zasshi; 1989 Sep; 64(5):642-7. PubMed ID: 2591876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of SUNCT after removal of a pituitary adenoma in mild acromegaly.
    Rozen TD
    Neurology; 2006 Aug; 67(4):724. PubMed ID: 16924039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case report of a 45-year-old man with uveal melanoma and suspect controlateral choroidal nævus].
    Farguette F; Bonnin N; Nezzar H; Chiambarretta F; Bacin F
    J Fr Ophtalmol; 2012 Oct; 35(8):635-41. PubMed ID: 22658842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.
    Quabbe HJ
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):107-19. PubMed ID: 7067156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
    Duan L; Zhu H; Xing B; Gu F
    BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment.
    Miranda-Rius J; Brunet-LLobet L; Lahor-Soler E; de Dios-Miranda D; Giménez-Rubio JA
    Head Face Med; 2017 May; 13(1):7. PubMed ID: 28490347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
    van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of acromegaly and Klinefelter syndrome in one patient.
    Ságová I; Pávai D; Kantárová D; Vaňuga A; Sadloňová J; Vaňuga P; Dragula M
    Vnitr Lek; 2019; 65(1):51-54. PubMed ID: 30823838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.